Department of the Navy, DOD.
The Department of the Navy hereby gives notice of its intent to grant to Cytoplex Biosciences, Inc., a revocable, nonassignable, exclusive license, to practice in the field of real Start Printed Page 9053time monitoring of molecular binding for pharmaceutical drug discovery in the United States and certain foreign countries, the Government-Owned inventions described in U.S. Patent No. 5,372,930: Sensors for Ultra-Low Concentration Molecular Recognition, Navy Case No. 73,568//U.S. Patent No. 5,807,758: Chemical and Biological Sensor Using an Ultra-Sensitive Force Transducer, Navy Case No. 76,628//U.S. Patent No. 5,981,297: Biosensor Using Magnetically-Detected Label, Navy Case No. 77,576//U.S. Patent No. 6,180,418: Force Discrimination Assay, Navy Case No. 78,183.
Anyone wishing to object to the grant of this license must file written objections along with supporting evidence, if any, not later than March 11, 2005.
Written objections are to be filed with the Naval Research Laboratory, Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375-5320.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Ms. Jane Kuhl, Head, Technology Transfer Office, NRL Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375-5320, telephone (202) 767-3083.
Due to U.S. Postal delays, please fax (202) 404-7920, E-Mail: email@example.com or use courier delivery to expedite response.Start Signature
Dated: February 17, 2005.
I.C. Le Moyne, Jr.,
Lieutenant, Judge Advocate General's Corps, U.S. Navy, Alternate Federal Register Liaison Officer.
[FR Doc. 05-3540 Filed 2-23-05; 8:45 am]
BILLING CODE 3810-FF-U